dTMS for Subjective Cognitive Decline — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

dTMS for Subjective Cognitive Decline — Stella

Home/Alzheimer Disease/

View on ClinicalTrials.gov

Recruiting

Back to Alzheimer Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Canada

Rotman Research Institute at Baycrest, Toronto, Ontario

Key details

Sponsor

Rotman Research Institute at Baycrest

Collaborators

Brainsway, Centre for Addiction and Mental Health

Enrollment target

~30 participants

Started

November 2023

Primary completion

October 2026

Age range

55 Years – 70 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.